|
|
|
Summary
of 1994 CPCRA Posters and Presentations
| 1st National Conference on Human Retroviruses and Related Infections, January 1994, Washington, DC |
Saravolatz L, Winslow D, Stein D, Dehlinger M, Collins G, Church T, Deyton L. Design and
Implementation of a Community Based Trial for the Comparison of Combination Zidovudine
(ZDV) with DDC or ddI to ZDV Monotherapy. Poster. CPCRA 007, NuCombo.
abstract
| The Biometric Society Spring Meeting, April 10-13, 1994, Cleveland, OH |
Goldman A, Bailey J. Confounding and Covariate Adjustments of Proportional Hazards Estimates of Relative Risk in AIDS Studies. Poster.
abstract
| 15th Annual Meeting of the Society for Clinical Trials, May 8-11, 1994, Houston, TX |
Brasler M, Ramser JC, Ragland K, Maiatico G. Case Study Approach in Protocol-Specific Training. Poster.
abstract
Neaton J, Deyton L, Schnittman S, Durfor C, Meschino J, Green L. Adverse Experience Reporting. Oral.
abstract
| 1994 ALA/ATS International Conference, May 22-25, 1994, Boston, Massachusetts |
Gordin F, Matts J, Cohn D, Nelson E, El-Sadr W. The Impact of HIV on Tuberculosis (TB) Drug Resistance Rates in the United States. Oral. CPCRA 017 TB/Registry.
abstract
| 5th International Meeting on Bayesian Statistics, June 15-17, 1994, Alicante, Spain |
Carlin B, Goldman A. Bayesian Evaluation of CD4 Count as a Surrogate Endpoint in Patients with Advanced HIV Infection. Oral.
abstract
| X International Conference on AIDS, August 7-12, 1994, Yokohama, Japan |
Sampson J, Ward T, Wentworth D, Wallace J. Effect of Concorde Study Release on
Anti-Retroviral (AR) Use in Community Programs for Clinical Research on AIDS (CPCRA)
Trials. Poster.
abstract
Torres RA, Tobin JN, Vaughn A, Podhurst L, Bolden B, Raschella N. Oral Lesions in Patients
with HIV Infection Enrolled in CPCRA Trials. Poster.
abstract
Saravolatz LD, Winslow D, Stein D, Dehlinger M, Collins G, Deyton LR. Design and
Implementation of a Community Based Trial for the Comparison of Combination ZDV with ddC
or ddI to ZDV Monotherapy. Poster. CPCRA 007 NuCombo.
abstract
Markowitz N, El-Sadr W, Wentworth D, Gordin F, Neaton J. Risk of PCP in a
Contemporaneous Cohort of HIV+ Patients. Poster.
abstract
John SL, Brown Jr LS, Neaton J, Wentworth D. Disease Progression and Survival Among
HIV-Infected Injecting Drug Users (IDUs) by Enrollment in Drug Abuse. Poster.
abstract
Fuentes L, El-Sadr w, Capps l, Hardy M, Guity C, Caras SP. An Effective System for Tracking
Challenging Populations in Community Based HIV Research. Poster.
abstract
El-Sadr W, Wentworth D, Cohn D, Gordin F, Brosgart C, Costanzo L, Walker J, Hafner R. A
Strategy for the Evaluation of Multiple Prophylactic Agents for Opportunistic Infections Among
HIV-Infected Patients. Oral.
abstract
Egger M, Wentworth D, von Overbeck J, Sherer R, Ledergerber B, Saravolatz LD. Mortality in
HIV Infection in Switzerland and U.S.A. Poster.
abstract
Brosgart C, Craig C, Louis T, Hillman D, Costanzo L, Timpone J, Scott JW, Nunley F, Stempien
MJ. Design and Demographics in a Multicenter Trial of Cytomegalovirus (CMV) Prophylaxis in
Advanced HIV Disease. Oral. CPCRA 023 CMV.
abstract
Abrams DI, Wentworth D, Neaton J, Sherer R, Deyton LR. Malignant Outcomes from a
Cross-Study Analysis of Patients Participating in a Community-Based Clinical Trials Program.
Poster.
abstract
Brown Jr LS, Neaton J, Wentworth D, Sherer R, Besch CL. Disease Progression and Survival
Among HIV-Infected Injecting Drug Users (IDUs) By Gender. Poster.
abstract
Besch CL, Morse EV, Simon PM, Bincsik A, Cefali F, Connett J, Child C, Costanzo L, Cox LE,
Landry S, Guity C, Ragland K, Ropka M. Determinants of Levels of Compliance in Patients
Enrolled in a PCP Prophylaxis Protocol (Community Programs for Clinical Research on AIDS
(CPCRA)): Baseline Data. Poster.
abstract
Pamphile R, Flam R, El-Sadr W. Tailoring HIV Care to Community Needs: The Harlem
Hospital Experience. Poster.
abstract
| 122nd American Public Health Association (APHA) Annual Meeting, October 30-November 3, 1994 |
Brown Jr LS, Neaton J, Wentworth D, Sherer R, Besch CL. Disease Progression and Survival Among HIV-Infected Injecting Drug Users (IDUs) by Gender. Printed. CPCRA 003 ODB.
abstract
|
|
